Summary & Overview
CPT 78650: Nuclear Medicine Localization of Cerebrospinal Fluid Leak
CPT code 78650 represents a diagnostic nuclear medicine study that detects and localizes cerebrospinal fluid (CSF) leakage using an injected radioactive tracer. Nationally relevant for neurology, otolaryngology, neurosurgery, and nuclear medicine practices, this code captures procedures performed when leak site localization is clinically necessary and other imaging is insufficient. Use of this code affects imaging utilization, specialist referral patterns, and payer coverage for advanced diagnostic workups.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides readers with an overview of typical sites of service, coding context, and payer coverage considerations. It summarizes common modifiers used with imaging services and notes when data are unavailable.
Readers will learn clinical context for when a CSF leak study is performed, how the service aligns with nuclear medicine workflows, and what to expect from payer coverage nationally. The document highlights benchmarks and policy considerations relevant to reimbursement and utilization of diagnostic nuclear imaging for CSF leak localization. Data not available in the input are clearly identified where applicable.
Billing Code Overview
CPT code 78650 describes a diagnostic nuclear imaging procedure used to detect and localize cerebrospinal fluid (CSF) leaks by administering a radioactive tracer and imaging the distribution of the tracer over time. This study is designed to identify active CSF leakage sites when clinical evaluation or other imaging modalities are inconclusive.
-
Service type: Diagnostic nuclear medicine imaging
-
Typical site of service: Hospital outpatient imaging center or nuclear medicine department
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult referred from neurology or otolaryngology for evaluation of suspected cerebrospinal fluid (CSF) leak after head trauma, skull base surgery, chronic rhinorrhea suspicious for CSF otorrhea/rhinorrhea, or positional headache suggesting low CSF pressure. The patient presents with clear unilateral nasal drainage that tests positive for beta-2 transferrin or with persistent post-operative drainage after transsphenoidal or skull base repair. Prior to the nuclear study, the clinical workflow commonly includes history and physical, specimen testing for beta-2 transferrin, high-resolution CT or MR imaging of the skull base, and ENT or neurosurgical consultation.
On the day of service the patient is positioned in nuclear medicine. An intrathecal injection of a radiotracer (commonly technetium-99m–labeled DTPA) is administered by an experienced provider or interventional radiology under sterile technique. Dynamic and delayed planar or SPECT images are acquired to localize tracer egress from the subarachnoid space to sinonasal or otic cavities. Results guide surgical planning or conservative management decisions; a neurosurgeon or otolaryngologist typically reviews imaging for localization of the leak and to determine the need for operative repair.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When physician interprets and reports the nuclear images separate from the facility technical component |